Article
Gene Correction for SCID-X1 in Long-Term Hematopoietic Stem Cells
2018-08-22
Abstract excerpt
Gene correction in human long-term hematopoietic stem cells (LT-HSCs) could be an effective therapy for monogenic diseases of the blood and immune system. High frequencies of reproducible targeted integration of a wild-type cDNA into the endogenous start codon of a gene in LT-HSCs could provide a robust genome editing approach to cure genetic diseases in which patients have different mutations throughout the gene....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8a382112-53c5-5718-9def-41c46c986e86
- DOI
- 10.1101/397463
